Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Aveanna Healthcare Holdings, Inc.
High uncertainty: The valuation methods show significant disagreement (>100% spread). Treat the range as a rough guide rather than a precise estimate.
Bear Case (25th pct.)
-48.0% vs price
Base Case (Median)
-21.0% vs price
Bull Case (75th pct.)
86.3% vs price
◇ = Current price | | Bear | Base | Bull
| Method | Est. Value | vs Price | Weight |
|---|---|---|---|
| DCF (Discounted Cash Flow) | $23.46 | 86.3% | High (40%) |
| PE Comparable | $28.29 | 124.7% | Medium (25%) |
| Graham Number | $5.03 | -60.0% | Medium (40%) |
| EV/EBITDA | $6.55 | -48.0% | Medium (20%) |
| EV/FCF | $9.95 | -21.0% | Medium (20%) |
Based on 5 out of 7 methods, AVAH appears fairly valued at the current price of $12.59. The base case fair value of $9.95 implies 21.0% downside.
Bear/base/bull cases represent the 25th, 50th, and 75th percentile of available method estimates. This is not financial advice. Valuation is inherently uncertain.